G

J

GLIGOROV , Joseph

Last name: GLIGOROV

First name: Joseph

2016 (v1)

Journal article

Metadata-only

A phase II study of afatinib, an irreversible ErbB family blocker, added to letrozole in patients with estrogen receptor-positive hormone-refractory metastatic breast cancer progressing on letrozole

Gunzer, Katharina Joly, Florence Ferrero, Jean-Marc

Phase II, open‑label study assessing the efficacy and safety of the ErbB family blocker afatinib combined with letrozole in estrogen receptor‑positive metastatic breast cancer (MBC) patients who had progressed on letrozole monotherapy. Adult females (N = 28) received oral afatinib (50 [n = 7], 40 [n = 13] or 30 [n = 8] mg/day) plus letrozole...

Uploaded on: February 28, 2023
April 5, 2016 (v1)

Journal article

Metadata-only

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study

Tabouret, Emeline Bertucci, François Pierga, Jean-Yves

International audience

Uploaded on: December 3, 2022